BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi C, Klein AP, Goggins M, Maitra A, Canto M, Ali S, Schulick R, Palmisano E, Hruban RH. Increased Prevalence of Precursor Lesions in Familial Pancreatic Cancer Patients. Clin Cancer Res 2009;15:7737-43. [PMID: 19996207 DOI: 10.1158/1078-0432.CCR-09-0004] [Cited by in Crossref: 162] [Cited by in F6Publishing: 178] [Article Influence: 11.6] [Reference Citation Analysis]
Number Citing Articles
1 Nero LD, Dabizzi E, Ceglie A, Ziola S, Zerbi A, Baron TH, Conio M. FAMILIAL PANCREATIC CANCER. Clin Res Hepatol Gastroenterol 2023;:102079. [PMID: 36681116 DOI: 10.1016/j.clinre.2023.102079] [Reference Citation Analysis]
2 Miyasaka Y, Kawamoto M. Long-term prognosis after resection of intraductal papillary mucinous neoplasms. Journal of the Japan Pancreas Society 2022;37:150-160. [DOI: 10.2958/suizo.37.150] [Reference Citation Analysis]
3 Ardeshna DR, Rangwani S, Cao T, Pawlik TM, Stanich PP, Krishna SG. Intraductal Papillary Mucinous Neoplasms in Hereditary Cancer Syndromes. Biomedicines 2022;10:1475. [DOI: 10.3390/biomedicines10071475] [Reference Citation Analysis]
4 Li X, He J, Xie K. Molecular signaling in pancreatic ductal metaplasia: emerging biomarkers for detection and intervention of early pancreatic cancer. Cell Oncol (Dordr) 2022. [PMID: 35290607 DOI: 10.1007/s13402-022-00664-x] [Reference Citation Analysis]
5 Zakaria A, Al-Share B, Klapman JB, Dam A. The Role of Endoscopic Ultrasonography in the Diagnosis and Staging of Pancreatic Cancer. Cancers (Basel) 2022;14:1373. [PMID: 35326524 DOI: 10.3390/cancers14061373] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Chattopadhyay TK. Advances in Gastrointestinal Surgery. GI Surgery Annual 2022. [DOI: 10.1007/978-981-19-0828-6_11] [Reference Citation Analysis]
7 Kothari S, Kaul V, Kothari TH. Reducing the Risk of and Screening for Pancreatic Cancer. Hepato-Pancreato-Biliary Malignancies 2022. [DOI: 10.1007/978-3-030-41683-6_35] [Reference Citation Analysis]
8 Khachfe HH, Habib JR, Nassour I, Al Harthi S, Jamali FR. Borderline Resectable and Locally Advanced Pancreatic Cancers: A Review of Definitions, Diagnostics, Strategies for Treatment, and Future Directions. Pancreas 2021;50:1243-9. [PMID: 34860806 DOI: 10.1097/MPA.0000000000001924] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol 2021;18:493-502. [PMID: 34002083 DOI: 10.1038/s41575-021-00457-x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 89] [Article Influence: 47.5] [Reference Citation Analysis]
10 Fong ZV, Castillo CF. Intraductal Papillary Mucinous Neoplasm. Clinical Pancreatology for Practising Gastroenterologists and Surgeons 2021. [DOI: 10.1002/9781119570097.ch73] [Reference Citation Analysis]
11 Ideno N, Nakata K, Nakamura M. What are the Appropriate Surgery and Postoperative Surveillance for Intraductal Papillary Mucinous Neoplasm? JDCR 2021;9:8-18. [DOI: 10.52927/jdcr.2021.9.1.8] [Reference Citation Analysis]
12 Dbouk M, Brewer Gutierrez OI, Lennon AM, Chuidian M, Shin EJ, Kamel IR, Fishman EK, He J, Burkhart RA, Wolfgang CL, Hruban RH, Goggins MG, Canto MI. Guidelines on management of pancreatic cysts detected in high-risk individuals: An evaluation of the 2017 Fukuoka guidelines and the 2020 International Cancer of the Pancreas Screening (CAPS) consortium statements. Pancreatology 2021;21:613-21. [PMID: 33593706 DOI: 10.1016/j.pan.2021.01.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
13 Sagami R, Yamao K, Nakahodo J, Minami R, Tsurusaki M, Murakami K, Amano Y. Pre-Operative Imaging and Pathological Diagnosis of Localized High-Grade Pancreatic Intra-Epithelial Neoplasia without Invasive Carcinoma. Cancers (Basel) 2021;13:945. [PMID: 33668239 DOI: 10.3390/cancers13050945] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
14 Campbell F, Verbeke CS. Pancreatic Intraepithelial Neoplasia. Pathology of the Pancreas 2021. [DOI: 10.1007/978-3-030-49848-1_8] [Reference Citation Analysis]
15 Oberhuber G. Pathobiology of Precursors to Pancreatic Cancer. Textbook of Pancreatic Cancer 2021. [DOI: 10.1007/978-3-030-53786-9_15] [Reference Citation Analysis]
16 Kothari S, Kaul V, Kothari TH. Reducing the Risk of and Screening for Pancreatic Cancer. Hepato-Pancreato-Biliary Malignancies 2021. [DOI: 10.1007/978-3-030-37482-2_35-1] [Reference Citation Analysis]
17 Balduzzi A, Andrianello S, Salvia R, Marchegiani G. IPMN as a Premalignant Condition. Textbook of Pancreatic Cancer 2021. [DOI: 10.1007/978-3-030-53786-9_49] [Reference Citation Analysis]
18 Campbell F, Verbeke CS. Hereditary Exocrine Disorders. Pathology of the Pancreas 2021. [DOI: 10.1007/978-3-030-49848-1_6] [Reference Citation Analysis]
19 Kogekar N, Diaz KE, Weinberg AD, Lucas AL. Surveillance of high-risk individuals for pancreatic cancer with EUS and MRI: A meta-analysis. Pancreatology 2020;20:1739-46. [PMID: 33077384 DOI: 10.1016/j.pan.2020.10.025] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
20 Paoli C, Carrer A. Organotypic Culture of Acinar Cells for the Study of Pancreatic Cancer Initiation. Cancers (Basel) 2020;12:E2606. [PMID: 32932616 DOI: 10.3390/cancers12092606] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
21 Tan M, Schaffalitzky de Muckadell OB, Jøergensen MT. Gene Expression Network Analysis of Precursor Lesions in Familial Pancreatic Cancer. J Pancreat Cancer 2020;6:73-84. [PMID: 32783019 DOI: 10.1089/pancan.2020.0007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
22 Abou-Kheir W, Mukherji D, Hadadeh O, Saleh E, Bahmad HF, Kanso M, Khalifeh M, Shamseddine A, Tamraz S, Jaafar R, Dagher C, Khalifeh I, Faraj W. CYR61/CCN1 expression in resected pancreatic ductal adenocarcinoma: A retrospective pilot study of the interaction between the tumors and their surrounding microenvironment. Heliyon 2020;6:e03842. [PMID: 32395647 DOI: 10.1016/j.heliyon.2020.e03842] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
23 Morani AC, Hanafy AK, Ramani NS, Katabathina VS, Yedururi S, Dasyam AK, Prasad SR. Hereditary and Sporadic Pancreatic Ductal Adenocarcinoma: Current Update on Genetics and Imaging. Radiol Imaging Cancer 2020;2:e190020. [PMID: 33778702 DOI: 10.1148/rycan.2020190020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
24 Matsubayashi H, Takaori K, Morizane C, Kiyozumi Y. Familial Pancreatic Cancer and Surveillance of High-Risk Individuals. Gut Liver 2019;13:498-505. [PMID: 30917631 DOI: 10.5009/gnl18449] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
25 Matsubayashi H, Notohara K, Hruban RH, Satoh T, Kaneko J, Sato J, Ishiwatari H, Ashida R, Uesaka K, Kiyozumi Y, Ono H. Multiple Carcinomas and Intraepithelial Neoplasms in a Case of Familial Pancreatic Cancer: Rapid Morphological Changes in the Pancreatic Cyst and Pathological Lesions Undetected by Clinical Images. Intern Med 2020;59:1041-6. [DOI: 10.2169/internalmedicine.3882-19] [Reference Citation Analysis]
26 De Jesus-acosta A, Narang A, Mauro L, Herman J, Jaffee EM, Laheru DA. Carcinoma of the Pancreas. Abeloff's Clinical Oncology 2020. [DOI: 10.1016/b978-0-323-47674-4.00078-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Balduzzi A, van Huijgevoort NCM, Marchegiani G, Engelbrecht M, Stoker J, Verheij J, Fockens P, van Hooft JE, Besselink MG. Surveillance and Intervention in IPMN. Translational Pancreatic Cancer Research 2020. [DOI: 10.1007/978-3-030-49476-6_2] [Reference Citation Analysis]
28 Klöppel G, Esposito I, Kasajima A, Konukiewitz B, Lüttges J, Sipos B. Solide und zystische nichtendokrine Tumoren des Pankreas. Pathologie 2020. [DOI: 10.1007/978-3-642-04557-8_24] [Reference Citation Analysis]
29 Goggins M, Overbeek KA, Brand R, Syngal S, Del Chiaro M, Bartsch DK, Bassi C, Carrato A, Farrell J, Fishman EK, Fockens P, Gress TM, van Hooft JE, Hruban RH, Kastrinos F, Klein A, Lennon AM, Lucas A, Park W, Rustgi A, Simeone D, Stoffel E, Vasen HFA, Cahen DL, Canto MI, Bruno M; International Cancer of the Pancreas Screening (CAPS) consortium. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut 2020;69:7-17. [PMID: 31672839 DOI: 10.1136/gutjnl-2019-319352] [Cited by in Crossref: 229] [Cited by in F6Publishing: 196] [Article Influence: 76.3] [Reference Citation Analysis]
30 Knight JC, Torres JB, Goldin R, Mosley M, Dias GM, Bravo LC, Kersemans V, Allen PD, Mukherjee S, Smart S, Cornelissen B. Early Detection in a Mouse Model of Pancreatic Cancer by Imaging DNA Damage Response Signaling. J Nucl Med 2020;61:1006-13. [PMID: 31862800 DOI: 10.2967/jnumed.119.234708] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
31 Cao CX, Sharib JM, Blanco AM, Goldberg D, Bracci P, Mukhtar RA, Esserman LJ, Kirkwood KS. Abdominal Imaging of Pancreatic Cysts and Cyst-Associated Pancreatic Cancer in BRCA1/2 Mutation Carriers: A Retrospective Cross-Sectional Study. J Am Coll Surg 2020;230:53-63.e1. [PMID: 31672679 DOI: 10.1016/j.jamcollsurg.2019.09.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Matsubayashi H, Kiyozumi Y, Ishiwatari H, Uesaka K, Kikuyama M, Ono H. Surveillance of Individuals with a Family History of Pancreatic Cancer and Inherited Cancer Syndromes: A Strategy for Detecting Early Pancreatic Cancers. Diagnostics (Basel) 2019;9:E169. [PMID: 31683730 DOI: 10.3390/diagnostics9040169] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
33 Diaz KE, Lucas AL. Familial Pancreatic Ductal Adenocarcinoma. Am J Pathol 2019;189:36-43. [PMID: 30558720 DOI: 10.1016/j.ajpath.2018.06.026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
34 Hutchings D, Jiang Z, Skaro M, Weiss MJ, Wolfgang CL, Makary MA, He J, Cameron JL, Zheng L, Klimstra DS, Brand RE, Singhi AD, Goggins M, Klein AP, Roberts NJ, Hruban RH. Histomorphology of pancreatic cancer in patients with inherited ATM serine/threonine kinase pathogenic variants. Mod Pathol. 2019;32:1806-1813. [PMID: 31285527 DOI: 10.1038/s41379-019-0317-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
35 Primavesi F, Stättner S, Schlick K, Kiesslich T, Mayr C, Klieser E, Urbas R, Neureiter D. Pancreatic cancer in young adults: changes, challenges, and solutions. Onco Targets Ther 2019;12:3387-400. [PMID: 31118690 DOI: 10.2147/OTT.S176700] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
36 Skaro M, Nanda N, Gauthier C, Felsenstein M, Jiang Z, Qiu M, Shindo K, Yu J, Hutchings D, Javed AA, Beckman R, He J, Wolfgang CL, Thompson E, Hruban RH, Klein AP, Goggins M, Wood LD, Roberts NJ. Prevalence of Germline Mutations Associated With Cancer Risk in Patients With Intraductal Papillary Mucinous Neoplasms. Gastroenterology 2019;156:1905-13. [PMID: 30716324 DOI: 10.1053/j.gastro.2019.01.254] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 7.5] [Reference Citation Analysis]
37 Thiruvengadam SS, Chuang J, Huang R, Girotra M, Park WG. Chronic pancreatitis changes in high-risk individuals for pancreatic ductal adenocarcinoma. Gastrointest Endosc 2019;89:842-851.e1. [PMID: 30145314 DOI: 10.1016/j.gie.2018.08.029] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
38 McNamara GPJ, Ali KN, Vyas S, Huynh T, Nyland M, Almanza D, Laronga C, Klapman J, Permuth JB. Characteristics and Clinical Outcomes of Individuals at High Risk for Pancreatic Cancer: A Descriptive Analysis from a Comprehensive Cancer Center. Gastrointest Disord (Basel) 2019;1:106-19. [PMID: 32601617 DOI: 10.3390/gidisord1010008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
39 Moutinho-Ribeiro P, Macedo G, Melo SA. Pancreatic Cancer Diagnosis and Management: Has the Time Come to Prick the Bubble? Front Endocrinol (Lausanne) 2018;9:779. [PMID: 30671023 DOI: 10.3389/fendo.2018.00779] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
40 Barnes CA, Krzywda E, Lahiff S, McDowell D, Christians KK, Knechtges P, Tolat P, Hohenwalter M, Dua K, Khan AH, Evans DB, Geurts J, Tsai S. Development of a high risk pancreatic screening clinic using 3.0 T MRI. Fam Cancer 2018;17:101-11. [PMID: 29101607 DOI: 10.1007/s10689-017-0057-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
41 Luchini C, Pea A, Yu J, He J, Salvia R, Riva G, Weiss MJ, Bassi C, Cameron JL, Hruban RH, Goggins M, Wolfgang CL, Scarpa A, Wood LD, Lawlor RT. Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primary. Mod Pathol 2019;32:659-65. [PMID: 30467323 DOI: 10.1038/s41379-018-0183-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
42 Riva G, Pea A, Pilati C, Fiadone G, Lawlor RT, Scarpa A, Luchini C. Histo-molecular oncogenesis of pancreatic cancer: From precancerous lesions to invasive ductal adenocarcinoma. World J Gastrointest Oncol 2018; 10(10): 317-327 [PMID: 30364837 DOI: 10.4251/wjgo.v10.i10.317] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
43 Lachter J, Rosenberg C, Hananiya T, Khamaysi I, Klein A, Yassin K, Half E. Screening to Detect Precursor Lesions of Pancreatic Adenocarcinoma in High-risk Individuals: A Single-center Experience. Rambam Maimonides Med J 2018;9. [PMID: 30309438 DOI: 10.5041/RMMJ.10353] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
44 Bartsch DK, Gercke N, Strauch K, Wieboldt R, Matthäi E, Wagner V, Rospleszcz S, Schäfer A, Franke FS, Mintziras I, Bauer C, Grote T, Figiel J, Di Fazio P, Burchert A, Reinartz S, Pogge von Strandmann E, Klöppel G, Slater EP. The Combination of MiRNA-196b, LCN2, and TIMP1 is a Potential Set of Circulating Biomarkers for Screening Individuals at Risk for Familial Pancreatic Cancer. J Clin Med 2018;7:E295. [PMID: 30241369 DOI: 10.3390/jcm7100295] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
45 Harrison JM, Castillo CF. To resect or not to resect: a review of pancreatic cyst disease management. Curr Opin Gastroenterol 2018;34:343-8. [PMID: 29912020 DOI: 10.1097/MOG.0000000000000463] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
46 Ideno N, Yamaguchi H, Okumara T, Huang J, Brun MJ, Ho ML, Suh J, Gupta S, Maitra A, Ghosh B. A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using invivoCRISPRCas9 mediated somatic recombination.. [DOI: 10.1101/398347] [Reference Citation Analysis]
47 Sikdar N, Saha G, Dutta A, Ghosh S, Shrikhande SV, Banerjee S. Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview. Curr Genomics 2018;19:444-63. [PMID: 30258276 DOI: 10.2174/1389202919666180221160753] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
48 Welinsky S, Lucas AL. Familial Pancreatic Cancer and the Future of Directed Screening. Gut Liver 2017;11:761-70. [PMID: 28609837 DOI: 10.5009/gnl16414] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
49 Paiella S, Salvia R, De Pastena M, Pollini T, Casetti L, Landoni L, Esposito A, Marchegiani G, Malleo G, De Marchi G, Scarpa A, D'Onofrio M, De Robertis R, Pan TL, Maggino L, Andrianello S, Secchettin E, Bonamini D, Melisi D, Tuveri M, Bassi C. Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results. Pancreatology 2018;18:420-8. [PMID: 29709409 DOI: 10.1016/j.pan.2018.04.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
50 Ikegawa T, Masuda A, Sakai A, Toyama H, Zen Y, Sofue K, Nakagawa T, Shiomi H, Takenaka M, Kobayashi T, Yoshida M, Arisaka Y, Okabe Y, Kutsumi H, Fukumoto T, Azuma T. Multifocal cysts and incidence of pancreatic cancer concomitant with intraductal papillary mucinous neoplasm. Pancreatology 2018;18:399-406. [PMID: 29685673 DOI: 10.1016/j.pan.2018.04.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
51 Gangi A, Malafa M, Klapman J. Endoscopic Ultrasound-Based Pancreatic Cancer Screening of High-Risk Individuals: A Prospective Observational Trial. Pancreas 2018;47:586-91. [PMID: 29683970 DOI: 10.1097/MPA.0000000000001038] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
52 Hata T, Suenaga M, Marchionni L, Macgregor-Das A, Yu J, Shindo K, Tamura K, Hruban RH, Goggins M. Genome-Wide Somatic Copy Number Alterations and Mutations in High-Grade Pancreatic Intraepithelial Neoplasia. Am J Pathol. 2018;188:1723-1733. [PMID: 29684357 DOI: 10.1016/j.ajpath.2018.03.012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
53 Klein AP. Familial Pancreatic Cancer. The Pancreas 2018. [DOI: 10.1002/9781119188421.ch91] [Reference Citation Analysis]
54 Noë M, Brosens LA, Offerhaus J. Pancreatic Cancer. The Pancreas 2018. [DOI: 10.1002/9781119188421.ch93] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
55 Lindquist CM, Miller FH, Hammond NA, Nikolaidis P. Pancreatic cancer screening. Abdom Radiol (NY) 2018;43:264-72. [PMID: 28840303 DOI: 10.1007/s00261-017-1308-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
56 Roberts NJ, Klein AP. Familial Pancreatic Cancer. Pancreatic Cancer 2018. [DOI: 10.1007/978-1-4939-7193-0_78] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
57 Das KK, Early D. Pancreatic cancer screening. Curr Treat Options Gastroenterol. 2017;15:562-575. [PMID: 28879469 DOI: 10.1007/s11938-017-0149-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
58 Pea A, Yu J, Rezaee N, Luchini C, He J, Dal Molin M, Griffin JF, Fedor H, Fesharakizadeh S, Salvia R, Weiss MJ, Bassi C, Cameron JL, Zheng L, Scarpa A, Hruban RH, Lennon AM, Goggins M, Wolfgang CL, Wood LD. Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas. Ann Surg 2017;266:133-41. [PMID: 27433916 DOI: 10.1097/SLA.0000000000001817] [Cited by in Crossref: 85] [Cited by in F6Publishing: 88] [Article Influence: 14.2] [Reference Citation Analysis]
59 Aronsson L, Andersson R, Ansari D. Intraductal papillary mucinous neoplasm of the pancreas - epidemiology, risk factors, diagnosis, and management. Scand J Gastroenterol 2017;52:803-15. [PMID: 28446039 DOI: 10.1080/00365521.2017.1318948] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
60 Liszka Ł. Incipient serous cystic neoplasia of the pancreas is a very rare phenomenon: a systematic prospective observation in pancreatectomy specimens. Hum Pathol 2017;70:139-41. [PMID: 28720434 DOI: 10.1016/j.humpath.2017.06.019] [Reference Citation Analysis]
61 Moutinho-Ribeiro P, Coelho R, Giovannini M, Macedo G. Pancreatic cancer screening: Still a delusion? Pancreatology 2017;17:754-65. [PMID: 28739291 DOI: 10.1016/j.pan.2017.07.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
62 Tanaka M, Fernández-Del Castillo C, Kamisawa T, Jang JY, Levy P, Ohtsuka T, Salvia R, Shimizu Y, Tada M, Wolfgang CL. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 2017;17:738-53. [PMID: 28735806 DOI: 10.1016/j.pan.2017.07.007] [Cited by in Crossref: 868] [Cited by in F6Publishing: 808] [Article Influence: 144.7] [Reference Citation Analysis]
63 Matsuda Y, Furukawa T, Yachida S, Nishimura M, Seki A, Nonaka K, Aida J, Takubo K, Ishiwata T, Kimura W, Arai T, Mino-Kenudson M. The Prevalence and Clinicopathological Characteristics of High-Grade Pancreatic Intraepithelial Neoplasia: Autopsy Study Evaluating the Entire Pancreatic Parenchyma. Pancreas 2017;46:658-64. [PMID: 28196020 DOI: 10.1097/MPA.0000000000000786] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
64 Patra KC, Bardeesy N, Mizukami Y. Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous Neoplasm. Clin Transl Gastroenterol. 2017;8:e86. [PMID: 28383565 DOI: 10.1038/ctg.2017.3] [Cited by in Crossref: 66] [Cited by in F6Publishing: 73] [Article Influence: 11.0] [Reference Citation Analysis]
65 Matsubayashi H, Takaori K, Morizane C, Maguchi H, Mizuma M, Takahashi H, Wada K, Hosoi H, Yachida S, Suzuki M, Usui R, Furukawa T, Furuse J, Sato T, Ueno M, Kiyozumi Y, Hijioka S, Mizuno N, Terashima T, Mizumoto M, Kodama Y, Torishima M, Kawaguchi T, Ashida R, Kitano M, Hanada K, Furukawa M, Kawabe K, Majima Y, Shimosegawa T. Familial pancreatic cancer: Concept, management and issues. World J Gastroenterol 2017; 23(6): 935-948 [PMID: 28246467 DOI: 10.3748/wjg.v23.i6.935] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 72] [Article Influence: 10.0] [Reference Citation Analysis]
66 Hata T, Dal Molin M, Hong SM, Tamura K, Suenaga M, Yu J, Sedogawa H, Weiss MJ, Wolfgang CL, Lennon AM, Hruban RH, Goggins MG. Predicting the Grade of Dysplasia of Pancreatic Cystic Neoplasms Using Cyst Fluid DNA Methylation Markers. Clin Cancer Res. 2017;23:3935-3944. [PMID: 28148542 DOI: 10.1158/1078-0432.ccr-16-2244] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
67 Ngamruengphong S, Canto MI. Screening for Pancreatic Cancer. Surg Clin North Am 2016;96:1223-33. [PMID: 27865274 DOI: 10.1016/j.suc.2016.07.016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
68 Stark AP, Hines OJ. Multifocal Branch-Duct Intraductal Papillary Mucinous Neoplasm. Case-Based Lessons in the Management of Complex Hepato-Pancreato-Biliary Surgery 2017. [DOI: 10.1007/978-3-319-50868-9_28] [Reference Citation Analysis]
69 Taucher V, Haybaeck J. Pancreatic Carcinogenesis. Mechanisms of Molecular Carcinogenesis – Volume 2 2017. [DOI: 10.1007/978-3-319-53661-3_5] [Reference Citation Analysis]
70 Al Efishat M, Allen PJ. Therapeutic Approach to Cystic Neoplasms of the Pancreas. Surg Oncol Clin N Am 2016;25:351-61. [PMID: 27013369 DOI: 10.1016/j.soc.2015.11.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
71 Marsoner K, Haybaeck J, Csengeri D, Waha JE, Schagerl J, Langeder R, Mischinger HJ, Kornprat P. Pancreatic resection for intraductal papillary mucinous neoplasm- a thirteen-year single center experience. BMC Cancer 2016;16:844. [PMID: 27809876 DOI: 10.1186/s12885-016-2887-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
72 Miller MS, Allen P, Brentnall TA, Goggins M, Hruban RH, Petersen GM, Rao CV, Whitcomb DC, Brand RE, Chari ST, Klein AP, Lubman DM, Rhim AD, Simeone DM, Wolpin BM, Umar A, Srivastava S, Steele VE, Rinaudo JA. Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report. Pancreas 2016;45:1080-91. [PMID: 27518363 DOI: 10.1097/MPA.0000000000000705] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
73 Griffin JF, Poruk KE, Wolfgang CL. Is It Time to Expand the Role of Total Pancreatectomy for IPMN? Dig Surg 2016;33:335-42. [PMID: 27215900 DOI: 10.1159/000445019] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
74 Adsay V, Mino-Kenudson M, Furukawa T, Basturk O, Zamboni G, Marchegiani G, Bassi C, Salvia R, Malleo G, Paiella S, Wolfgang CL, Matthaei H, Offerhaus GJ, Adham M, Bruno MJ, Reid MD, Krasinskas A, Klöppel G, Ohike N, Tajiri T, Jang KT, Roa JC, Allen P, Fernández-del Castillo C, Jang JY, Klimstra DS, Hruban RH; Members of Verona Consensus Meeting, 2013. Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting. Ann Surg 2016;263:162-77. [PMID: 25775066 DOI: 10.1097/SLA.0000000000001173] [Cited by in Crossref: 170] [Cited by in F6Publishing: 180] [Article Influence: 24.3] [Reference Citation Analysis]
75 Serrao EM, Kettunen MI, Rodrigues TB, Dzien P, Wright AJ, Gopinathan A, Gallagher FA, Lewis DY, Frese KK, Almeida J, Howat WJ, Tuveson DA, Brindle KM. MRI with hyperpolarised [1-13C]pyruvate detects advanced pancreatic preneoplasia prior to invasive disease in a mouse model. Gut 2016;65:465-75. [PMID: 26347531 DOI: 10.1136/gutjnl-2015-310114] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 8.1] [Reference Citation Analysis]
76 Bhutani MS, Koduru P, Joshi V, Saxena P, Suzuki R, Irisawa A, Yamao K. The role of endoscopic ultrasound in pancreatic cancer screening. Endosc Ultrasound. 2016;5:8-16. [PMID: 26879161 DOI: 10.4103/2303-9027.175876] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
77 Zhao C, Yang S, Lin L, Weng S, Liu Q, Liu A, Lin X. Chronocoulometric biosensor for K-ras point mutation detection based on E. coli DNA ligase and AuNPs amplification effects. Sensors and Actuators B: Chemical 2016;223:946-51. [DOI: 10.1016/j.snb.2014.06.091] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
78 Hernandez YG, Lucas AL. MicroRNA in pancreatic ductal adenocarcinoma and its precursor lesions. World J Gastrointest Oncol 2016; 8(1): 18-29 [PMID: 26798434 DOI: 10.4251/wjgo.v8.i1.18] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 57] [Article Influence: 7.1] [Reference Citation Analysis]
79 Roberts NJ, Klein AP. Familial Pancreatic Cancer. Pancreatic Cancer 2016. [DOI: 10.1007/978-1-4939-6631-8_78-1] [Reference Citation Analysis]
80 Nayor J, Grover S, Syngal S. Evaluation and Surveillance Strategies for Patients at Increased Risk of Pancreatic Cancer. Pancreatic Masses 2016. [DOI: 10.1007/978-3-319-19677-0_15] [Reference Citation Analysis]
81 Norris AL, Roberts NJ, Jones S, Wheelan SJ, Papadopoulos N, Vogelstein B, Kinzler KW, Hruban RH, Klein AP, Eshleman JR. Familial and sporadic pancreatic cancer share the same molecular pathogenesis. Fam Cancer. 2015;14:95-103. [PMID: 25240578 DOI: 10.1007/s10689-014-9755-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 27] [Article Influence: 5.1] [Reference Citation Analysis]
82 Esposito I, Segler A, Steiger K, Klöppel G. Pathology, genetics and precursors of human and experimental pancreatic neoplasms: An update. Pancreatology 2015;15:598-610. [PMID: 26365060 DOI: 10.1016/j.pan.2015.08.007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
83 Brosens LA, Hackeng WM, Offerhaus GJ, Hruban RH, Wood LD. Pancreatic adenocarcinoma pathology: changing “landscape”. J Gastrointest Oncol. 2015;6:358-374. [PMID: 26261723 DOI: 10.3978/j.issn.2078-6891.2015.032] [Cited by in F6Publishing: 26] [Reference Citation Analysis]
84 Krah NM, De La O JP, Swift GH, Hoang CQ, Willet SG, Chen Pan F, Cash GM, Bronner MP, Wright CV, MacDonald RJ. The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma. Elife. 2015;4. [PMID: 26151762 DOI: 10.7554/elife.07125] [Cited by in Crossref: 95] [Cited by in F6Publishing: 103] [Article Influence: 11.9] [Reference Citation Analysis]
85 Singhi AD, Ishida H, Ali SZ, Goggins M, Canto M, Wolfgang C, Meriden Z, Roberts N, Klein AP, Hruban RH. A histomorphologic comparison of familial and sporadic pancreatic cancers. Pancreatology 2015;15:387-91. [PMID: 25959245 DOI: 10.1016/j.pan.2015.04.003] [Reference Citation Analysis]
86 L VK. PANCREATIC CARCINOMA: REVIEW OF LITERATURE. jemds 2015;4:6517-6531. [DOI: 10.14260/jemds/2015/945] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
87 Tanaka M. Current roles of endoscopy in the management of intraductal papillary mucinous neoplasm of the pancreas. Dig Endosc 2015;27:450-7. [PMID: 25588761 DOI: 10.1111/den.12434] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
88 Eshleman JR, Norris AL, Sadakari Y, Debeljak M, Borges M, Harrington C, Lin E, Brant A, Barkley T, Almario JA, Topazian M, Farrell J, Syngal S, Lee JH, Yu J, Hruban RH, Kanda M, Canto MI, Goggins M. KRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound. Clin Gastroenterol Hepatol 2015;13:963-9.e4. [PMID: 25481712 DOI: 10.1016/j.cgh.2014.11.028] [Cited by in Crossref: 60] [Cited by in F6Publishing: 45] [Article Influence: 7.5] [Reference Citation Analysis]
89 Bartsch DK, Fendrich V, Langer P. Familial Cancer of the Pancreas. Pancreatic Cancer, Cystic Neoplasms and Endocrine Tumors 2015. [DOI: 10.1002/9781118307816.ch3] [Reference Citation Analysis]
90 Flanagan MR, Jayaraj A, Xiong W, Yeh MM, Raskind WH, Pillarisetty VG. Pancreatic intraductal papillary mucinous neoplasm in a patient with Lynch syndrome. World J Gastroenterol 2015; 21(9): 2820-2825 [PMID: 25759555 DOI: 10.3748/wjg.v21.i9.2820] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
91 Tanaka M. Thirty years of experience with intraductal papillary mucinous neoplasm of the pancreas: from discovery to international consensus. Digestion 2014;90:265-72. [PMID: 25591885 DOI: 10.1159/000370111] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
92 Singhi AD, Ishida H, Ali SZ, Goggins M, Canto M, Wolfgang C, Meriden Z, Roberts N, Klein AP, Hruban RH. A histomorphologic comparison of familial and sporadic pancreatic cancers. Pancreatology 2015;15:387-91. [PMID: 25959245 DOI: 10.1016/j.pan.2015.04.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
93 Lennon AM, Victor D, Zaheer A, Ostovaneh MR, Jeh J, Law JK, Rezaee N, Molin MD, Ahn YJ, Wu W, Khashab MA, Girotra M, Ahuja N, Makary MA, Weiss MJ, Hirose K, Goggins M, Hruban RH, Cameron A, Wolfgang CL, Singh VK, Gurakar A. Liver transplant patients have a risk of progression similar to that of sporadic patients with branch duct intraductal papillary mucinous neoplasms. Liver Transpl 2014;20:1462-7. [PMID: 25155689 DOI: 10.1002/lt.23983] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
94 Sadakari Y, Kanda M, Maitani K, Borges M, Canto MI, Goggins M. Mutant KRAS and GNAS DNA Concentrations in Secretin-Stimulated Pancreatic Fluid Collected from the Pancreatic Duct and the Duodenal Lumen. Clin Transl Gastroenterol 2014;5:e62. [PMID: 25393586 DOI: 10.1038/ctg.2014.14] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
95 Esposito I, Konukiewitz B, Schlitter AM, Klöppel G. Pathology of pancreatic ductal adenocarcinoma: Facts, challenges and future developments. World J Gastroenterol 2014; 20(38): 13833-13841 [PMID: 25320520 DOI: 10.3748/wjg.v20.i38.13833] [Cited by in CrossRef: 59] [Cited by in F6Publishing: 58] [Article Influence: 6.6] [Reference Citation Analysis]
96 Hassid BG, Lucas AL, Salomao M, Weng C, Liu F, Khanna LG, Kumar S, Hwang C, Chabot JA, Frucht H. Absence of pancreatic intraepithelial neoplasia predicts poor survival after resection of pancreatic cancer. Pancreas 2014;43:1073-7. [PMID: 24987871 DOI: 10.1097/MPA.0000000000000161] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
97 Chiaro MD, Segersvärd R, Lohr M, Verbeke C. Early detection and prevention of pancreatic cancer: Is it really possible today? World J Gastroenterol 2014; 20(34): 12118-12131 [PMID: 25232247 DOI: 10.3748/wjg.v20.i34.12118] [Cited by in CrossRef: 91] [Cited by in F6Publishing: 95] [Article Influence: 10.1] [Reference Citation Analysis]
98 Hruban RH, Klimstra DS. Adenocarcinoma of the pancreas. Semin Diagn Pathol 2014;31:443-51. [PMID: 25441308 DOI: 10.1053/j.semdp.2014.08.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
99 Lami G, Biagini MR, Galli A. Endoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancer. World J Gastrointest Endosc 2014; 6(7): 272-285 [PMID: 25031786 DOI: 10.4253/wjge.v6.i7.272] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
100 Slater EP, Strauch K, Rospleszcz S, Ramaswamy A, Esposito I, Klöppel G, Matthäi E, Heeger K, Fendrich V, Langer P, Bartsch DK. MicroRNA-196a and -196b as Potential Biomarkers for the Early Detection of Familial Pancreatic Cancer. Transl Oncol 2014;7:464-71. [PMID: 24956938 DOI: 10.1016/j.tranon.2014.05.007] [Cited by in Crossref: 48] [Cited by in F6Publishing: 58] [Article Influence: 5.3] [Reference Citation Analysis]
101 Lennon AM, Wolfgang CL, Canto MI, Klein AP, Herman JM, Goggins M, Fishman EK, Kamel I, Weiss MJ, Diaz LA, Papadopoulos N, Kinzler KW, Vogelstein B, Hruban RH. The Early Detection of Pancreatic Cancer: What Will It Take to Diagnose and Treat Curable Pancreatic Neoplasia? Cancer Res 2014;74:3381-9. [DOI: 10.1158/0008-5472.can-14-0734] [Cited by in Crossref: 157] [Cited by in F6Publishing: 173] [Article Influence: 17.4] [Reference Citation Analysis]
102 Matthaei H, Wu J, Dal Molin M, Shi C, Perner S, Kristiansen G, Lingohr P, Kalff JC, Wolfgang CL, Kinzler KW, Vogelstein B, Maitra A, Hruban RH. GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as "incipient IPMNs". Am J Surg Pathol 2014;38:360-3. [PMID: 24525507 DOI: 10.1097/PAS.0000000000000117] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
103 Singhi AD, Pai RK, Kant JA, Bartholow TL, Zeh HJ, Lee KK, Wijkstrom M, Yadav D, Bottino R, Brand RE. The histopathology of PRSS1 hereditary pancreatitis. Am J Surg Pathol. 2014;38:346-353. [PMID: 24525505 DOI: 10.1097/pas.0000000000000164] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
104 Distler M, Aust D, Weitz J, Pilarsky C, Grützmann R. Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN. Biomed Res Int 2014;2014:474905. [PMID: 24783207 DOI: 10.1155/2014/474905] [Cited by in Crossref: 97] [Cited by in F6Publishing: 109] [Article Influence: 10.8] [Reference Citation Analysis]
105 Tanaka M. Macroscopic Morphological Classification and Its Significance. Intraductal Papillary Mucinous Neoplasm of the Pancreas 2014. [DOI: 10.1007/978-4-431-54472-2_1] [Reference Citation Analysis]
106 Mauro LA, Herman JM, Jaffee EM, Laheru DA. Carcinoma of the Pancreas. Abeloff's Clinical Oncology 2014. [DOI: 10.1016/b978-1-4557-2865-7.00081-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
107 Rebours V, Le Faouder J, Laouirem S, Mebarki M, Albuquerque M, Camadro JM, Léger T, Ruszniewski P, Lévy P, Paradis V, Bedossa P, Couvelard A. In situ proteomic analysis by MALDI imaging identifies ubiquitin and thymosin-β4 as markers of malignant intraductal pancreatic mucinous neoplasms. Pancreatology 2014;14:117-24. [PMID: 24650966 DOI: 10.1016/j.pan.2013.12.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
108 Klein AP, Lindström S, Mendelsohn JB, Steplowski E, Arslan AA, Bueno-de-Mesquita HB, Fuchs CS, Gallinger S, Gross M, Helzlsouer K, Holly EA, Jacobs EJ, Lacroix A, Li D, Mandelson MT, Olson SH, Petersen GM, Risch HA, Stolzenberg-Solomon RZ, Zheng W, Amundadottir L, Albanes D, Allen NE, Bamlet WR, Boutron-Ruault MC, Buring JE, Bracci PM, Canzian F, Clipp S, Cotterchio M, Duell EJ, Elena J, Gaziano JM, Giovannucci EL, Goggins M, Hallmans G, Hassan M, Hutchinson A, Hunter DJ, Kooperberg C, Kurtz RC, Liu S, Overvad K, Palli D, Patel AV, Rabe KG, Shu XO, Slimani N, Tobias GS, Trichopoulos D, Van Den Eeden SK, Vineis P, Virtamo J, Wactawski-Wende J, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte A, Chanock SJ, Hoover RN, Hartge P, Kraft P. An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. PLoS One 2013;8:e72311. [PMID: 24058443 DOI: 10.1371/journal.pone.0072311] [Cited by in Crossref: 87] [Cited by in F6Publishing: 91] [Article Influence: 8.7] [Reference Citation Analysis]
109 Del Chiaro M, Verbeke C, Salvia R, Klöppel G, Werner J, McKay C, Friess H, Manfredi R, Van Cutsem E, Löhr M, Segersvärd R; European Study Group on Cystic Tumours of the Pancreas. European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis 2013;45:703-11. [PMID: 23415799 DOI: 10.1016/j.dld.2013.01.010] [Cited by in Crossref: 324] [Cited by in F6Publishing: 366] [Article Influence: 32.4] [Reference Citation Analysis]
110 Fendrich V, Langer P, Bartsch DK. Familial pancreatic cancer--status quo. Int J Colorectal Dis 2014;29:139-45. [PMID: 23948969 DOI: 10.1007/s00384-013-1760-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
111 Bartsch DK, Dietzel K, Bargello M, Matthaei E, Kloeppel G, Esposito I, Heverhagen JT, Gress TM, Slater EP, Langer P. Multiple small "imaging" branch-duct type intraductal papillary mucinous neoplasms (IPMNs) in familial pancreatic cancer: indicator for concomitant high grade pancreatic intraepithelial neoplasia? Fam Cancer 2013;12:89-96. [PMID: 23179793 DOI: 10.1007/s10689-012-9582-y] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
112 Capurso G, Boccia S, Salvia R, Del Chiaro M, Frulloni L, Arcidiacono PG, Zerbi A, Manta R, Fabbri C, Ventrucci M, Tarantino I, Piciucchi M, Carnuccio A, Boggi U, Leoncini E, Costamagna G, Delle Fave G, Pezzilli R, Bassi C, Larghi A; Italian Association for Study of Pancreas (AISP), Intraductal Papillary Mucinous Neoplasm (IPMN) Study Group. Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study. Am J Gastroenterol 2013;108:1003-9. [PMID: 23458848 DOI: 10.1038/ajg.2013.42] [Cited by in Crossref: 85] [Cited by in F6Publishing: 72] [Article Influence: 8.5] [Reference Citation Analysis]
113 Kanda M, Sadakari Y, Borges M, Topazian M, Farrell J, Syngal S, Lee J, Kamel I, Lennon AM, Knight S, Fujiwara S, Hruban RH, Canto MI, Goggins M. Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia. Clin Gastroenterol Hepatol 2013;11:719-30.e5. [PMID: 23200980 DOI: 10.1016/j.cgh.2012.11.016] [Cited by in Crossref: 121] [Cited by in F6Publishing: 125] [Article Influence: 12.1] [Reference Citation Analysis]
114 Poruk KE, Firpo MA, Adler DG, Mulvihill SJ. Screening for pancreatic cancer: why, how, and who? Ann Surg 2013;257:17-26. [PMID: 22895395 DOI: 10.1097/SLA.0b013e31825ffbfb] [Cited by in Crossref: 143] [Cited by in F6Publishing: 163] [Article Influence: 14.3] [Reference Citation Analysis]
115 Zamboni G, Hirabayashi K, Castelli P, Lennon AM. Precancerous lesions of the pancreas. Best Pract Res Clin Gastroenterol 2013;27:299-322. [PMID: 23809247 DOI: 10.1016/j.bpg.2013.04.001] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 5.0] [Reference Citation Analysis]
116 Canto MI, Harinck F, Hruban RH, Offerhaus GJ, Poley JW, Kamel I, Nio Y, Schulick RS, Bassi C, Kluijt I, Levy MJ, Chak A, Fockens P, Goggins M, Bruno M; International Cancer of Pancreas Screening (CAPS) Consortium. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut 2013;62:339-47. [PMID: 23135763 DOI: 10.1136/gutjnl-2012-303108] [Cited by in Crossref: 535] [Cited by in F6Publishing: 493] [Article Influence: 53.5] [Reference Citation Analysis]
117 Crnogorac-Jurcevic T, Chelala C, Barry S, Harada T, Bhakta V, Lattimore S, Jurcevic S, Bronner M, Lemoine NR, Brentnall TA. Molecular analysis of precursor lesions in familial pancreatic cancer. PLoS One 2013;8:e54830. [PMID: 23372777 DOI: 10.1371/journal.pone.0054830] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
118 Campbell F, Verbeke CS. Pancreatic Intraepithelial Neoplasia. Pathology of the Pancreas 2013. [DOI: 10.1007/978-1-4471-2449-8_8] [Reference Citation Analysis]
119 Campbell F, Verbeke CS. Hereditary Exocrine Disorders. Pathology of the Pancreas 2013. [DOI: 10.1007/978-1-4471-2449-8_6] [Reference Citation Analysis]
120 Brosens LAA, Offerhaus GJ. Molecular Pathology of Pancreatic Cancer Precursor Lesions. Molecular Genetics of Pancreatic Cancer 2013. [DOI: 10.1007/978-1-4614-6549-2_2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
121 Tanaka M. Revised points of the international consensus guidelines 2012 for the management of IPMN. Journal of the Japan Pancreas Society 2013;28:121-130. [DOI: 10.2958/suizo.28.121] [Reference Citation Analysis]
122 Loos M, Michalski CW, Kleeff J. Asymptomatic pancreatic lesions: New insights and clinical implications. World J Gastroenterol 2012; 18(33): 4474-4477 [PMID: 22969218 DOI: 10.3748/wjg.v18.i33.4474] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
123 Bartsch DK, Gress TM, Langer P. Familial pancreatic cancer--current knowledge. Nat Rev Gastroenterol Hepatol 2012;9:445-53. [PMID: 22664588 DOI: 10.1038/nrgastro.2012.111] [Cited by in Crossref: 108] [Cited by in F6Publishing: 107] [Article Influence: 9.8] [Reference Citation Analysis]
124 Segura PP, Ponce CG, Ramón Y Cajal T, Blanch RS, Aranda E. Hereditary pancreatic cancer: molecular bases and their application in diagnosis and clinical management: a guideline of the TTD group. Clin Transl Oncol 2012;14:553-63. [PMID: 22855135 DOI: 10.1007/s12094-012-0840-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
125 Hong SM, Vincent A, Kanda M, Leclerc J, Omura N, Borges M, Klein AP, Canto MI, Hruban RH, Goggins M. Genome-wide somatic copy number alterations in low-grade PanINs and IPMNs from individuals with a family history of pancreatic cancer. Clin Cancer Res 2012;18:4303-12. [PMID: 22723370 DOI: 10.1158/1078-0432.CCR-12-1075] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
126 Rebours V, Couvelard A, Peyroux JL, Sauvanet A, Hammel P, Ruszniewski P, Lévy P. Familial intraductal papillary mucinous neoplasms of the pancreas. Dig Liver Dis 2012;44:442-6. [PMID: 21824831 DOI: 10.1016/j.dld.2011.07.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
127 Tanaka M, Fernández-del Castillo C, Adsay V, Chari S, Falconi M, Jang JY, Kimura W, Levy P, Pitman MB, Schmidt CM, Shimizu M, Wolfgang CL, Yamaguchi K, Yamao K; International Association of Pancreatology. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012;12:183-97. [PMID: 22687371 DOI: 10.1016/j.pan.2012.04.004] [Cited by in Crossref: 1714] [Cited by in F6Publishing: 1702] [Article Influence: 155.8] [Reference Citation Analysis]
128 Kanda M, Matthaei H, Wu J, Hong SM, Yu J, Borges M, Hruban RH, Maitra A, Kinzler K, Vogelstein B, Goggins M. Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia. Gastroenterology 2012;142:730-733.e9. [PMID: 22226782 DOI: 10.1053/j.gastro.2011.12.042] [Cited by in Crossref: 449] [Cited by in F6Publishing: 479] [Article Influence: 40.8] [Reference Citation Analysis]
129 Canto MI, Hruban RH, Fishman EK, Kamel IR, Schulick R, Zhang Z, Topazian M, Takahashi N, Fletcher J, Petersen G, Klein AP, Axilbund J, Griffin C, Syngal S, Saltzman JR, Mortele KJ, Lee J, Tamm E, Vikram R, Bhosale P, Margolis D, Farrell J, Goggins M; American Cancer of the Pancreas Screening (CAPS) Consortium. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 2012;142:796-804; quiz e14-5. [PMID: 22245846 DOI: 10.1053/j.gastro.2012.01.005] [Cited by in Crossref: 443] [Cited by in F6Publishing: 526] [Article Influence: 40.3] [Reference Citation Analysis]
130 Sipos B, Henopp T. [Precursor lesions of pancreatobiliary cancer]. Pathologe 2011;32 Suppl 2:224-31. [PMID: 21909795 DOI: 10.1007/s00292-011-1513-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
131 Nehra D, Oyarvide VM, Mino-Kenudson M, Thayer SP, Ferrone CR, Wargo JA, Muzikansky A, Finkelstein D, Warshaw AL, Castillo CF. Intraductal papillary mucinous neoplasms: does a family history of pancreatic cancer matter? Pancreatology 2012;12:358-63. [PMID: 22898638 DOI: 10.1016/j.pan.2012.05.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
132 Lv WC, Cui YF. Advance in understanding the epidemiology and etiology of pancreatic cancer. Shijie Huaren Xiaohua Zazhi 2011; 19(27): 2805-2809 [DOI: 10.11569/wcjd.v19.i27.2805] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
133 Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet. 2011;378:607-620. [PMID: 21620466 DOI: 10.1016/s0140-6736(10)62307-0] [Cited by in Crossref: 1606] [Cited by in F6Publishing: 1776] [Article Influence: 133.8] [Reference Citation Analysis]
134 Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet. 2011;378:607-620. [PMID: 21620466 DOI: 10.1016/so140-6736(10)62307-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
135 Stoita A, Penman ID, Williams DB. Review of screening for pancreatic cancer in high risk individuals. World J Gastroenterol 2011; 17(19): 2365-2371 [PMID: 21633635 DOI: 10.3748/wjg.v17.i19.2365] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
136 Liszka L, Pająk J, Mrowiec S, Zielińska-Pająk E, Gołka D, Lampe P. Precursor lesions of early onset pancreatic cancer. Virchows Arch 2011;458:439-51. [PMID: 21369801 DOI: 10.1007/s00428-011-1056-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
137 Pancreas and ampullary region. Rosai and Ackerman's Surgical Pathology 2011. [DOI: 10.1016/b978-0-323-06969-4.00028-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
138 Tanaka M. Controversies in the management of pancreatic IPMN. Nat Rev Gastroenterol Hepatol 2011;8:56-60. [PMID: 21212775 DOI: 10.1038/nrgastro.2010.193] [Cited by in Crossref: 79] [Cited by in F6Publishing: 65] [Article Influence: 6.6] [Reference Citation Analysis]
139 Verbeke CS. Intraductal papillary-mucinous neoplasia of the pancreas: Histopathology and molecular biology. World J Gastrointest Surg 2010; 2(10): 306-313 [PMID: 21160835 DOI: 10.4240/wjgs.v2.i10.306] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]